The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site
Abstract GPR139 is an orphan G protein-coupled receptor expressed in the brain, in particular in the habenula, hypothalamus and striatum. It has therefore been suggested that GPR139 is a possible target for metabolic disorders and Parkinson’s disease. Several surrogate agonist series have been publi...
Main Authors: | Anne Cathrine Nøhr, Willem Jespers, Mohamed A. Shehata, Leonard Floryan, Vignir Isberg, Kirsten Bayer Andersen, Johan Åqvist, Hugo Gutiérrez-de-Terán, Hans Bräuner-Osborne, David E. Gloriam |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-04-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-01049-z |
Similar Items
-
In vivo Characterization of a Selective, Orally Available, and Brain Penetrant Small Molecule GPR139 Agonist
by: James R. Shoblock, et al.
Published: (2019-03-01) -
Identification of Histamine H3 Receptor Ligands Using a New Crystal Structure Fragment-based Method
by: Ida Osborn Frandsen, et al.
Published: (2017-07-01) -
Phenylalanine and Tryptophan Intake of Hyperactive Children with Autism
by: Puspito Arum, et al.
Published: (2017-12-01) -
Habenula GPR139 is associated with fear learning in the zebrafish
by: Nisa Roy, et al.
Published: (2021-03-01) -
QligFEP: an automated workflow for small molecule free energy calculations in Q
by: Willem Jespers, et al.
Published: (2019-04-01)